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BACKGROUND: Mild hypoxic-ischemic encephalopathy (HIE) is increasingly recognized as a risk factor for neonatal brain injury. We
examined the timing and pattern of brain injury in mild HIE.
METHODS: This retrospective cohort study includes infants with mild HIE treated at 9 hospitals. Neonatal brain MRIs were scored by
2 reviewers using a validated classiﬁcation system, with discrepancies resolved by consensus. Severity and timing of MRI brain
injury (i.e., acute, subacute, chronic) was scored on the subset of MRIs that were performed at or before 8 days of age.
RESULTS: Of 142 infants with mild HIE, 87 (61%) had injury on MRI at median age 5 (IQR 4–6) days. Watershed (23%), deep gray
(20%) and punctate white matter (18%) injury were most common. Among the 125 (88%) infants who received a brain MRI at
≤8 days, mild (44%) injury was more common than moderate (11%) or severe (4%) injury. Subacute (37%) lesions were more
commonly observed than acute (32%) or chronic lesions (1%).
CONCLUSION: Subacute brain injury is common in newborn infants with mild HIE. Novel neuroprotective treatments for mild HIE
will ideally target both subacute and acute injury mechanisms.
Pediatric Research (2022) 92:1731–1736; https://doi.org/10.1038/s41390-022-02026-7
IMPACT:
●
●
●

Almost two-thirds of infants with mild HIE have evidence of brain injury on MRI obtained in the early neonatal period.
Subacute brain injury was seen in 37% of infants with mild HIE.
Neuroprotective treatments for mild HIE will ideally target both acute and subacute injury mechanisms.

INTRODUCTION
Hypoxic-ischemic encephalopathy (HIE), an important cause of
neonatal encephalopathy (NE), affects approximately 1.5 out of
every 1000 live births1 and is a major cause for developmental
disability in children, leading to cerebral palsy, seizures, and
cognitive impairment. Severity of HIE is clinically evaluated,
commonly using the Sarnat grading system2. Neonates with mild
encephalopathy by Sarnat grading are considered to have a more
favorable neurodevelopmental prognosis3. For this reason, randomized controlled trials testing therapeutic hypothermia4,5 (TH) and
other neuroprotective therapies for HIE6,7 have excluded mild HIE
patients.
In recent years, mild HIE has been increasingly linked to
adverse outcomes including brain injury and neurodevelopmental

impairment. For instance, recent studies suggest that 38–61%8–13 of
neonates with mild HIE have abnormal brain magnetic resonance
imaging (MRI), a similar proportion as described in the moderate to
severe HIE population. Furthermore, a recent meta-analysis of
functional outcomes identiﬁed neurodevelopmental impairment in
up to 25% of infants with mild HIE14.
The timing of brain injury in infants with mild HIE has not been
well studied. Whether the brain injury seen in infants with mild
HIE occurred remote from the time of birth allowing the infant
time to partially recover by the time of delivery is unknown. A
better understanding of the timing and pattern of brain injury in
mild HIE may help inform future studies of novel treatments. We
examined the timing, pattern, and severity of MRI brain injury in a
multicenter cohort of infants with mild HIE.
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METHODS
In this retrospective cohort study, we identiﬁed term and near-term infants
born at ≥36 weeks gestational age at nine U.S. hospitals in 2013–2019 who
were diagnosed with mild HIE. We evaluated all newborn infants with HIE
at these hospitals in 2017–2019 for potential enrollment in High-dose
Erythropoietin for Asphyxia and Encephalopathy (HEAL)7, a phase 3 trial

investigating the efﬁcacy of erythropoietin as a neuroprotective
therapy for moderate to severe HIE. Infants were assessed using a
modiﬁed Sarnat examination7 by trained examiners. Infants with
mild HIE were excluded from the HEAL Trial and were instead
enrolled in the current observational study. During the years
2013–2015, ﬁve of the sites had systematically identiﬁed infants
with mild HIE using the same Sarnat criteria for a phase 2 clinical
trial of erythropoietin for HIE15; the infants with mild HIE who were
excluded from the phase 2 trial were also included in the current
study. We deﬁned mild HIE as at least one Sarnat exam
abnormality of any severity in any of the six categories (i.e.,
consciousness, activity, tone, posture, primitive reﬂexes, or
autonomic nervous system) documented at any time between
1–6 h of age16, but fewer than three moderate/severe Sarnat
abnormalities as required to meet the deﬁnition of moderate to
severe HIE4,5. Additionally, infants had evidence of perinatal
depression with at least one of the following: 10-minute Apgar
score <5, need for resuscitation at 10 min, pH < 7.00 in an arterial
or venous cord or infant gas performed by 60 min of age, or base
deﬁcit ≥15 mmol/L in a cord or infant gas performed by 60 min of
age. We included infants regardless of whether they were born at
the participating hospital or transferred from an outside hospital
for tertiary care. Patients were excluded from the study if any of
the following were present: birthweight <1800 g (i.e., intrauterine
growth restriction), head circumference <30 cm, or encephalopathy occurring after birth (i.e., post-natal collapse).
For all infants with mild HIE, we determined the following from medical
record review: gestational age; birthweight; clinical diagnosis of chorioamnionitis; sentinel event deﬁned as placental abruption, uterine
rupture, shoulder dystocia, prolapsed cord or tight nuchal cord; treatment
with TH; and length of hospital stay.
Study subjects received a brain MRI using local neuroimaging protocols
as part of clinical care. These neuroimaging studies were performed on
MRIs from three manufacturers: General Electric (46%), Siemens (34%) and
Philips (20%). Most studies (78%) were performed at 3 T magnetic ﬁeld
strength, while the remaining were performed at 1.5 T. In infants who were
treated with TH, the brain MRI was typically performed after rewarming
(i.e., at 4–6 days of age). All subjects who did not receive TH were enrolled
at a single hospital (UTSW) where TH is not used to treat mild HIE; these
subjects also received a brain MRI as part of their routine clinical care.
Brain MRIs were scored independently by 2 reviewers with extensive
experience using a validated HIE severity classiﬁcation system17; discrepancies were then resolved by consensus among all four members of the
neuroimaging core (Y.L., R.M., J.W., A.M.). The MRI scoring system assigns a
severity score based on extent of signal abnormality in speciﬁed regions of
the brain on T1, T2, and DWI sequences. The global injury score (range
0–138) is the sum of all regional numeric injury scores. Severity of injury was
pre-deﬁned as: 0 = no injury; 1–11 = mild injury; 12–32 = moderate injury;
33–138 = severe injury17. The quality of the imaging with respect to motion
artifact was recorded on a four-point scale: none; mild (unlikely to impact
interpretation), moderate (may impact interpretation), and severe (obfuscates
interpretation). A global injury severity score was calculated only in patients
imaged within 8 days of age, because diffusion-weighted signal abnormalities, which constitute a component of the scoring system, typically disappear
or undergo “pseudonormalization” by approximately 8 days of age18,19.
Examples of different patterns and acuities of injury are provided in Figs. 1–4.
Each patient was classiﬁed as having one or more of the following patterns
of brain injury: none, watershed, deep gray, punctate white matter lesions,
arterial ischemic stroke, focal parenchymal lesions, hippocampal injury, and
atypical lesions. Atypical lesions were deﬁned as any abnormality not ﬁtting
into the previously described categories, and thus are atypical ﬁndings in the
setting of HIE. Intraparenchymal and subdural hemorrhages were scored as
trace, mild/moderate if no mass effect, and severe if mass effect was present.
Intraventricular hemorrhage was similarly classiﬁed as trace, mild/moderate if
no ventricular dilation, and severe if ventricular dilation was present.
Subarachnoid hemorrhage was scored as either trace or focal.

a

b

Fig. 1 Acute, deep gray pattern of hypoxic ischemic brain injury.
a ADC map demonstrating restricted diffusion involving the
posterior limbs of the internal capsules (white arrows) and
ventrolateral thalami (black arrows) and b T2-weighted imaging
demonstrating hyperintensity involving the posterior limb of the
internal capsule (white arrows) and bilateral thalami (black arrows).

a

b

Fig. 2 Acute arterial watershed pattern of hypoxic ischemic brain
injury. a DWI demonstrating restricted diffusion (white arrow) and
b T2 demonstrating hyperintensity (black arrow) in the left superior
parietal white matter.

a

b

Fig. 3 Acute, severe deep gray and watershed pattern of injury.
DWI (a) and ADC map (b) demonstrate restricted diffusion
involving the deep gray (white arrows denoting reduced diffusion
in the putamen, globi paladi, ventrolateral thalamus, posterior limb
of the internal capsule) and watershed pattern (white arrowheads
denoting reduced diffusion involving the subcortical white matter),
with global injury score 84. Additional reduced diffusion involving
the genu and splenium of the corpus callosum (asterisks) is
compatible with pre-Wallerian degeneration from intramyelinic
edema.
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Fig. 4 Multiple injury patterns and acuities of injury. Acute punctate white matter injury (white arrows) with reduced diffusion (a) and T1
hyperintensity (b). Additional subacute injury to the right thalamus (black arrows) with no reduced diffusion (c) and T2 hyperintensity (d), and
without volume loss.
Table 1.

Clinical features of 142 infants with mild HIE stratiﬁed by presence of brain injury on MRI.
All
N = 142

Brain injury
N = 87

No brain injury
N = 55

p value

Gestational age (mean, weeks)

39.2

39.1

39.4

0.25

Birthweight (mean, grams)

3292 g

3295

3288

0.93

Male

64%

70%

55%

0.06

Born at outside hospital

95 (67%)

57 (66%)

38 (69%)

0.66

Lowest cord pH (mean)

7.00

7.00

7.01

0.91

5-min Apgar score (median, range)

5 (0–9)

4.5 (0–9)

4 (1–9)

0.28

10-min Apgar score (median, range)

6 (1–9)

6 (1–9)

6 (1–9)

0.34

5 or greater Sarnat abnormalities

62%

61%

64%

0.75

Therapeutic Hypothermia

85%

83%

89%

0.30

Clinical chorioamnionitis

35%

35%

35%

0.99

Sentinel events

34%

36%

33%

0.72

Length of hospitalization (median days, IQR)

8 (6–13)

9 (7–14)

8 (6–12)

0.64

The time window of brain injury was assessed in all brain MRI studies
performed within 8 days of age. Acute injury was deﬁned by the presence
of restricted diffusion. Subacute injury was deﬁned by presence of an
abnormality on T1 and T2-weighted imaging without accompanying
diffusion abnormality or volume loss. Chronic injury was deﬁned by the
presence of parenchymal volume loss.
We examined how brain injury timing and severity varied by clinical
factors such as antenatal complications and treatment with TH using
Wilcoxon Rank-Sum test for continuous variables and Pearson’s chisquared test for categorical variables. We also examined whether the
frequency of brain injury varied by the number of Sarnat exam
abnormalities. Finally, we compared the rate of MRI brain injury in subjects
who met criteria for mild HIE based on more restrictive deﬁnitions used in
two clinical trials: (1) MEND (NCT03071861): mild HIE = one or two
moderate or severe modiﬁed Sarnat abnormality in any of the six
categories20; and (2) TIME (NCT04176471): mild HIE = at least 2 Sarnat
abnormalities of any severity, but not qualifying for moderate/severe
encephalopathy. This study was approved by the Institutional Review
Boards at all participating institutions.

RESULTS
We identiﬁed 149 infants with mild HIE, 7 of whom were excluded
due to unavailable MRI (5) or MRI that was not interpretable due to
severe motion degradation (2). The remaining 142 infants
comprise the study population. Brain MRIs were performed at a
median age of 5 days (interquartile range (IQR) 4–6) and 70% had
no motion, 23% had mild motion, and 7% had moderate motion
on T1, T2, or DWI sequences. Infants with mild HIE exhibited
signiﬁcant cord blood acidosis and depressed Apgar scores
(Table 1). Both clinical chorioamnionitis and sentinel events were
present in about one-third of subjects.
Brain parenchymal injury was present in 87 (61%) infants with
mild HIE. No clinical factors were signiﬁcantly associated with
presence of brain injury (Table 1). The most common brain injury
Pediatric Research (2022) 92:1731 – 1736

patterns were watershed (22%), deep gray nuclei (20%), punctate
white matter (18%), and atypical lesions (18%, Table 2). Twentytwo percent had more than one injury pattern. Among the 142
infants who met our study inclusion criteria, 127 (89%) also met
the TIME study deﬁnition, and 134 (94%) met the MEND20 study
deﬁnition of mild HIE. The frequency of brain injury was
unchanged when we analyzed only infants who met these more
restrictive criteria (60% using TIME study deﬁnition; 61% using
MEND study deﬁnition).
Intracranial hemorrhage was present in 60 (42%) infants,
including 21 (15%) with moderate or severe hemorrhage. The
most common location of hemorrhage was subdural (34%),
followed by intraventricular (12%), intraparenchymal (6%), and
subarachnoid (3%). Three subdural hemorrhages were classiﬁed as
large enough to exhibit mass effect and one large intraventricular
hemorrhage led to non-communicating hydrocephalus. There
were no cases of large intraparenchymal hemorrhage.
The majority (85%) of infants in our cohort were treated with
TH. The 21 infants with mild HIE who did not receive TH exhibited
no difference in mean lowest cord pH when compared to the
treated group (Table 2). Infants who did not receive TH had a
higher median 5-min Apgar than those who did receive TH (7 vs.
4, p < 0.0001). Infants who underwent TH did not differ
signiﬁcantly from the untreated group in frequency of brain
injury on MRI (60% vs. 71%, p = 0.30, Table 2). However, watershed
injury was less common in those who received TH (18% vs. 48%,
p = 0.003).
Among the 125 (88%) of infants with mild HIE who received an
early brain MRI at ≤8 days of age, 75 (60%) had evidence of
parenchymal brain injury. The median injury score in this group
with early MRI was 5 (IQR 2–9, range 0–84) and when present, the
brain injury was predominantly mild (Table 3). A greater
percentage of infants exhibited subacute (37%) than acute
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Table 2. Clinical features and MRI patterns of brain injury in infants with mild HIE who received therapeutic hypothermia, compared to those who
did not receive therapeutic hypothermia.
All
N = 142

Therapeutic hypothermia
N = 121

No therapeutic hypothermia
N = 21

P value

Gestational age (mean, weeks)

39.2

39.3

38.8

0.92

Birthweight (mean, grams)

3292

3389

3276

0.41

Male

91 (64%)

17 (81%)

74 (61%)

0.08

Lowest cord pH (mean)

7.0

7.0

7.0

0.57

5-minute Apgar (median, range)

5 (3–6)

4 (3–6)

7 (5–8)

<0.0001

10-minute Apgar (median, range)

6 (5–7)

6 (5–7)

6 (5–8)

0.54

Age at scan (median, days)

5 (4–6)

5 (4–7)

4 (3–4)

<0.001

Brain injury present

87 (61%)

72 (60%)

15 (71%)

0.30

Clinical features

Brain MRI

Pattern of injury
Normal

55 (39%)

49 (40%)

6 (29%)

0.30

Watershed

32 (23%)

22 (18%)

10 (48%)

0.002

Deep gray

28 (20%)

24 (20%)

4 (19%)

0.92

Punctate white matter

24 (17%)

19 (16%)

5 (24%)

0.48

Focal parenchymal

12 (8%)

10 (8%)

2 (10%)

0.95

Arterial ischemic stroke

5 (4%)

4 (3%)

1 (5%)

0.62

Hippocampal

2 (1%)

2 (2%)

0 (0%)

0.53

Atypicala

27 (19%)

25 (21%)

2 (10%)

0.29

Multiple patterns

31 (22%)

26 (21%)

5 (24)%

0.26

Atypical patterns included: other supratentorial white matter signal abnormality (N = 8), cerebellar white matter signal abnormality (N = 5), callosal and/or
anterior commissural reduced diffusion in the absence of other deep gray or white matter signal abnormality (N = 5), cerebellar hemorrhage (N = 2), signal
abnormality suggestive of kernicterus (N = 2).

a

Table 3.

Injury severity and acuity among 125 infants with mild HIE who received a brain MRI at or before 8 days of age.

Injury score (median; IQR)

All
N = 125

Therapeutic hypothermia
N = 104

No therapeutic hypothermia
N = 21

P value

5 (2–9)

5 (2–9)

6 (2–10)

0.97

50 (40%)

44 (42%)

6 (29%)

Injury severity
No injury

0.59

Mild

55 (44%)

43 (42%)

12 (57%)

Moderate

14 (11%)

12 (12%)

2 (10%)

Severe

5 (4%)

4 (4%)

1 (5%)

Injury acuity
No injury

50 (40%)

44 (42%)

6 (29%)

0.24

Acute

40 (32%)

34 (33%)

21 (29%)

0.71

Subacute

46 (37%)

36 (35%)

10 (48%)

0.26

Chronic

1 (1%)

1 (1%)

0 (0%)

0.65

Multiple acuities

18 (14%)

15 (14%)

3 (14%)

0.76

(32%) or chronic (1%) injury. There were no clinical factors that
were signiﬁcantly associated with either severity or timing of brain
injury in the subgroup of infants with early MRI.
DISCUSSION
In this large multicenter study designed to evaluate the timing
and pattern of brain injury in infants with mild HIE, we found that
about two-thirds of infants had evidence of brain injury on MRI.
The high rate of subacute lesions in our cohort is a novel ﬁnding,
as few studies have evaluated the timing of brain injury in mild
HIE. Additionally, we found that variations in the deﬁnition of mild

HIE have minimal impact on the observed frequency of brain
injury.
Among infants with mild HIE, 39% exhibited subacute brain
injury deﬁned as T1 or T2 signal abnormality without restricted
diffusion to signify acute injury, and without volume loss to signify
chronic injury. As we excluded infants imaged after 8 days of age
from this analysis, this relatively high rate of subacute signal
abnormality cannot be explained by pseudonormalization of
diffusion abnormalities. Acute injury was also common, occurring
in 31% of subjects. Although a lack of diffusion restriction within
an area of brain injury suggests that the injury occurred at least
over a week before the time of imaging, it is not possible to
Pediatric Research (2022) 92:1731 – 1736
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pinpoint the exact time of hypoxic-ischemic brain injury based on
neuroimaging. However, the large percentage of infants with
subacute injury in our study raises the possibility that mild
encephalopathy may in many cases reﬂect injury that occurred
early enough to provide the infant time to partially recover by the
time of delivery, and thus to exhibit milder signs of
encephalopathy.
The issue of timing of injury is an important consideration when
designing treatments for HIE. The intracellular mechanisms of
hypoxic-ischemic brain injury are complex and evolve over time21.
Following a primary phase of neuronal cell death, many surviving
cells will partially recover during a latent phase which provides a
window of opportunity to intervene with therapies such as TH22.
The latent phase is then followed by a secondary phase of cell
death due to numerous intracellular mechanisms such as
apoptosis, inﬂammation and mitochondrial failure22. It is known
that TH is an effective therapy for reducing the risk of death or
neurologic disability in infants with moderate to severe HIE23.
However, no randomized controlled trials have tested the efﬁcacy
of TH for treating milder cases of HIE, and observational data
supporting the use of this treatment for mild HIE show
inconsistent results13,24. The frequent subacute injury observed
in our cohort raises the possibility that TH may be less
neuroprotective in infants with mild HIE, given that the baby
may be born beyond the neuroprotective window for TH to be
effective, namely six hours after injury. However, this hypothesis
remains a speculation and studies evaluating the efﬁcacy of TH for
mild HIE are urgently needed.
The 61% rate of MRI brain injury among all subjects in our
cohort is consistent with previous estimates of the frequency of
brain injury in mild HIE (38–61%)8–13. White matter injury in an
arterial watershed distribution was the most common pattern of
brain abnormality seen in our cohort, a ﬁnding that is also
consistent with previous studies of mild HIE8,11,12,25–29. The
predominance of mild severity of brain injury is also consistent
with previous reports9,11.
Whereas infants with mild HIE were previously thought to have
an excellent neurologic prognosis, a recent review suggests that
up to 25% of infants with mild HIE are at risk for neurodevelopmental deﬁcits in infancy or childhood14. In the PRIME prospective
observational study, for instance, 16% of infants with mild HIE had
disability at 18–22 months of age28,30. There has been a signiﬁcant
therapeutic drift in recent years with many hospitals offering TH to
infants with mild HIE, because we lack other neuroprotective
therapies for this condition, and because the evolving nature of
the infant exam can make it challenging to establish the severity
of HIE with certainty. A recent survey of practices in the United
Kingdom found that 76% of centers that offer TH for moderate to
severe HIE also provide this therapy to infants with mild HIE31, a
practice that is shared by eight of our nine study sites.
It is important to note that our observational study was not
designed to determine the efﬁcacy of TH for mild HIE. Although
the rate of brain injury was no different in the group that did and
did not receive TH, we did observe a signiﬁcantly lower frequency
of watershed injury in the TH group, a ﬁnding that has been
reported in other observational cohorts13,25,32. The lower rate of
watershed injury suggests a possible beneﬁt to the TH, since
selection bias resulting from sicker infants being preferentially
chosen to receive TH should make it more difﬁcult to appreciate
MRI improvements among infants who received TH. However,
conclusions regarding the potential beneﬁt of TH for mild HIE will
require well-designed clinical trials or comparative efﬁcacy studies
that are speciﬁcally designed to evaluate this question.
Prior studies have found that perinatal sentinel events such as
placental abruption or uterine rupture are present in about onethird of cases of moderate to severe HIE33,34, which is similar to the
34% rate of sentinel events seen in our cohort. In our cohort, 70%
of male infants had brain injury on MRI, compared to 55% of
Pediatric Research (2022) 92:1731 – 1736

female infants. Although this difference was not statistically
signiﬁcant (P = 0.06), it may reﬂect the sexual dimorphism that has
been well described in HIE35.
A challenge faced by researchers studying mild HIE has been
the lack of a universally accepted set of diagnostic criteria9,20,28.
Our study found that the rate and severity of brain injury did not
vary signiﬁcantly when we applied two additional study deﬁnitions of mild HIE that are currently being used in research settings.
These ﬁndings are reassuring and suggest that the lack of a
consensus deﬁnition of mild HIE is unlikely to cause large
discrepancies in neuroimaging ﬁndings or rates of brain injury.
Our study has several strengths. In addition to its large size, we
identiﬁed subjects in a systematic fashion at multiple tertiary care
centers, thus increasing generalizability. Almost all subjects
received a brain MRI within the ﬁrst 8 days of age, allowing us
to evaluate the timing of brain injury in mild HIE. However, our
study has important limitations. Because of the observational
nature of the study, the fact that only a small number of infants
did not receive TH, and because all infants who did not receive TH
were enrolled at a single site, we are unable to determine whether
TH improved neuroimaging outcomes in our cohort. The study
further is limited by potential selection bias since hospitals that
performed TH in neonates with mild HIE may have selected more
severely affected infants in the mild HIE spectrum to receive this
treatment, thus artiﬁcially increasing the rate of brain MRI
abnormalities in our cohort. Our study lacked harmonization of
MRI protocols across institutions and platforms. We lacked
information regarding aEEG ﬁndings which could be used to
conﬁrm the presence of mild HIE, and the study also does not
include neurodevelopmental outcomes. Finally, although we infer
that T2 signal abnormality in a pattern compatible with HIE likely
represents subacute injury, we cannot exclude the possibility that
some of these lesions may also represent areas of inﬂammation.
In conclusion, we found that subacute brain injury was common
in infants with mild HIE. Novel neuroprotective therapies will
ideally target both subacute and acute injury mechanisms. The
large number of infants with subacute injury suggests that mild
HIE may be the result of injury that occurred hours or days prior to
delivery. Future clinical trials are needed to evaluate the efﬁcacy of
TH and other therapeutic agents20 as a treatment for infants with
mild HIE, and to determine which subset of these patients will
most likely beneﬁt from these treatments.
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